CD47 and cancer: As shown in Fig. 1A, mouse cancer cells −4T1, LCC, B16F10 and CT26- had CD47+ cells with high expression rates of 99.5%, 99.4%, 99.6%, 99.8%, respectively, in comparison with the isotype control.